Clinical Trials Directory

Trials / Unknown

UnknownNCT01101204

The Effects of Hypolipemic and Antidiabetic Treatment on Cytokines

Effects of High and Low Doses of Metformin, Fenofibrate and Simvastatin, Administered Together and in Sequence With Lifestyle Intervention on Lipid Profile, Glucose Metabolism, Low-grade Inflammation and Hemostasis in Patient's Blood Plasma in Type 2 Diabetic Patients With Serious Mixed Dyslipidemia

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
200 (estimated)
Sponsor
Medical University of Silesia · Academic / Other
Sex
All
Age
35 Years – 64 Years
Healthy volunteers
Accepted

Summary

The study is planned to show whether combined hypolipemic and antidiabetic therapy with various daily dosages influence the fasting plasma glucose, insulin sensitivity and proinflammatory cytokines in diabetic and dyslipidemic subjects.

Conditions

Interventions

TypeNameDescription
DRUGMetformin 1000mg, simvastatin 10mg and fenofibrate 100mgPatient will take three pill consisting of metformin 1000mg, simvastatin 10mg and fenofibrate 100mg.

Timeline

Start date
2012-07-01
Primary completion
2012-10-01
Completion
2012-12-01
First posted
2010-04-09
Last updated
2012-07-09

Locations

1 site across 1 country: Poland

Source: ClinicalTrials.gov record NCT01101204. Inclusion in this directory is not an endorsement.